Arcutis Biotherapeutics, Inc. (ARQT)
NASDAQ: ARQT · Real-Time Price · USD
20.86
-0.15 (-0.71%)
At close: May 22, 2026, 4:00 PM EDT
20.56
-0.30 (-1.42%)
After-hours: May 22, 2026, 7:52 PM EDT

Arcutis Biotherapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
35.0743.2271.9589.3254.8897.99
Short-Term Investments
189.24178.08156.62183.46355.95290.61
Cash & Short-Term Investments
224.31221.29228.57272.79410.82388.6
Cash Growth
12.88%-3.19%-16.21%-33.60%5.72%35.88%
Accounts Receivable
144.38146.2373.0725.818.46-
Inventory
37.3922.6314.5313.137.51-
Other Current Assets
31.9821.0819.6618.710.6114.17
Total Current Assets
438.06411.23335.82330.43437.41402.77
Net Property, Plant & Equipment
5.45.512.993.94.65.3
Other Intangible Assets
14.2514.819.486.447.19-
Other Long-Term Assets
2.31.420.60.60.080.08
Total Assets
460432.97348.89341.37449.27408.15
Accounts Payable
18.312.5314.2211.998.837.35
Accrued Expenses
136.96116.3166.7933.9428.3225.54
Current Portion of Long-Term Debt
7.951----
Current Portion of Leases
---0.740.660.43
Total Current Liabilities
163.2129.8481.0146.6737.8133.33
Long-Term Debt
101.47107.96107.2201.8197.7772.35
Long-Term Leases
5.255.272.563.384.124.77
Other Long-Term Liabilities
0.430.430.570.85-0.03
Total Long-Term Liabilities
107.15113.66110.34206.03201.8977.15
Total Liabilities
270.36243.49191.35252.7239.69110.48
Common Stock
0.010.010.010.010.010.01
Additional Paid-in Capital
1,3401,3281,2791,071930.43706.23
Accumulated Other Comprehensive Income
-0.51-0.04-0.010-1.09-0.26
Retained Earnings
-1,149-1,138-1,122-981.9-719.76-408.31
Shareholders' Equity
189.65189.48157.5488.67209.58297.68
Total Liabilities & Equity
460432.97348.89341.37449.27408.15
Total Debt
114.67114.23109.77205.92202.5477.56
Net Cash (Debt)
109.64107.07118.8166.87208.28311.04
Net Cash Growth
2.40%-9.88%77.67%-67.89%-33.04%10.68%
Net Cash Per Share
0.840.840.980.963.796.30
Book Value
189.65189.48157.5488.67209.58297.68
Book Value Per Share
1.451.491.301.283.816.03
Tangible Book Value
175.4174.67148.0682.23202.39297.68
Tangible Book Value Per Share
1.341.371.221.193.686.03
Updated May 6, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q